Clinical Trial Update: A Randomized Pilot Study of Evolocumab Plus Nivolumab/Ipilimumab in Treatment-Naïve Patients With Metastatic NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 randomized pilot trial is investigating evolocumab in combination with nivolumab/ipilimumab for treatment-naïve metastatic non-small cell lung cancer;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Evolocumab (evolocumab)
• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Scott Antonia | Conditions: Lung Cancer Metastatic | Phase 2 | Status: ACTIVE_NOT_RECRUITING